Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

209 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Microcrystalline paclitaxel-coated balloon for revascularization of femoropopliteal artery disease: Three-year outcomes of the randomized BIOPAC trial.
Nowakowski P, Uchto W, Hrycek E, Kachel M, Ludyga T, Polczyk F, Żurakowski A, Kaźmierczak P, Granada JF, Nowakowska I, Kiesz RS, Milewski KP, Buszman PE, Buszman PP. Nowakowski P, et al. Among authors: granada jf. Vasc Med. 2021 Aug;26(4):401-408. doi: 10.1177/1358863X20988360. Epub 2021 Mar 9. Vasc Med. 2021. PMID: 33686879 Clinical Trial.
Experimental evaluation of pharmacokinetic profile and biological effect of a novel paclitaxel microcrystalline balloon coating in the iliofemoral territory of swine.
Buszman PP, Milewski K, Zurakowski A, Pajak J, Jelonek M, Gasior P, Peppas A, Tellez A, Granada JF, Buszman PE. Buszman PP, et al. Among authors: granada jf. Catheter Cardiovasc Interv. 2014 Feb;83(2):325-33. doi: 10.1002/ccd.24982. Epub 2013 Oct 23. Catheter Cardiovasc Interv. 2014. PMID: 23703720
Stenting and Adjunctive Delivery of Paclitaxel Via Balloon Coating Versus Durable Polymeric Matrix for De Novo Coronary Lesions: Clinical and Angiographic Results from the Prospective Randomized Trial.
Żurakowski A, Buszman PP, Milewski KP, Janas A, Gorycki B, Kondys M, Gąsior P, Michalak M, Boxberger M, Peppas A, Granada JF, Buszman PE. Żurakowski A, et al. Among authors: granada jf. J Interv Cardiol. 2015 Aug;28(4):348-57. doi: 10.1111/joic.12210. J Interv Cardiol. 2015. PMID: 26224390 Free article. Clinical Trial.
Stent healing response following delivery of paclitaxel via durable polymeric matrix versus iopromide-based balloon coating in the familial hypercholesterolaemic swine model of coronary injury.
Buszman PP, Tellez A, Afari M, Cheng Y, Conditt GB, McGregor JC, Milewski K, Stenoien M, Kaluza GL, Granada JF. Buszman PP, et al. Among authors: granada jf. EuroIntervention. 2013 Aug 22;9(4):510-6. doi: 10.4244/EIJV9I4A82. EuroIntervention. 2013. PMID: 23965356 Free article.
Tissue uptake, distribution, and healing response after delivery of paclitaxel via second-generation iopromide-based balloon coating: a comparison with the first-generation technology in the iliofemoral porcine model.
Buszman PP, Tellez A, Afari ME, Peppas A, Conditt GB, Rousselle SD, McGregor JC, Stenoien M, Kaluza GL, Granada JF. Buszman PP, et al. Among authors: granada jf. JACC Cardiovasc Interv. 2013 Aug;6(8):883-90. doi: 10.1016/j.jcin.2013.04.013. JACC Cardiovasc Interv. 2013. PMID: 23968706 Free article.
Differences in vessel healing following delivery of everolimus or paclitaxel: a comparative experimental study using identical stent and biodegradable polymer platforms.
Buszman PP, Milewski K, Pająk J, Jelonek M, Orlik B, Krauze A, Gwiazdowska-Nowotka B, Wojakowski W, Tellez A, Granada JF, Buszman PE. Buszman PP, et al. Among authors: granada jf. EuroIntervention. 2014 Oct;10(6):724-31. doi: 10.4244/EIJV10I6A125. EuroIntervention. 2014. PMID: 24469344 Free article.
Clinical Randomized Trial Evaluating Novel, Microcrystalline, and Biocompatible Polymer Paclitaxel-Coated Balloon for the Treatment of Femoropopliteal Occlusive Disease: The BIOPAC Trial.
Buszman PP, Nowakowski P, Milewski K, Orlik B, Żurakowski A, Ludyga T, Polczyk F, Dębiński M, Jelonek M, Kachel M, Gąsior M, Granada JF, Kiesz RS, Buszman PE. Buszman PP, et al. Among authors: granada jf. JACC Cardiovasc Interv. 2018 Dec 10;11(23):2436-2438. doi: 10.1016/j.jcin.2018.07.029. JACC Cardiovasc Interv. 2018. PMID: 30522679 Free article. Clinical Trial. No abstract available.
Evaluation of efficacy and dose response of different paclitaxel-coated balloon formulations in a novel swine model of iliofemoral in-stent restenosis.
Milewski K, Afari ME, Tellez A, Aboodi MS, Kim JS, Cheng Y, Conditt GB, McGregor JC, Yi GH, Stenoien M, Langanki D, Krueger CG, Kaluza GL, Granada JF. Milewski K, et al. Among authors: granada jf. JACC Cardiovasc Interv. 2012 Oct;5(10):1081-8. doi: 10.1016/j.jcin.2012.06.012. JACC Cardiovasc Interv. 2012. PMID: 23078739 Free article.
Comparable clinical safety and efficacy of biodegradable versus durable polymer paclitaxel eluting stents despite shorter dual antiplatelet therapy: insights from a multicenter, propensity score-matched registry.
Buszman PP, Orlik B, Trela B, Milewski K, Kozlowski M, Pruski M Jr, Drzewiecki J, Peppas A, Granada JF, Kaluza GL, Buszman PE. Buszman PP, et al. Among authors: granada jf. Catheter Cardiovasc Interv. 2013 Sep 1;82(3):E155-62. doi: 10.1002/ccd.24732. Epub 2012 Dec 3. Catheter Cardiovasc Interv. 2013. PMID: 23109067
In vivo comparison of key quantitative parameters measured with 3D peripheral angiography, 2D peripheral quantitative angiography and intravascular ultrasound.
Zasada W, Slezak M, Pociask E, Malinowski KP, Proniewska K, Buszman P, Milewski K, Granada JF, Kaluza GL. Zasada W, et al. Among authors: granada jf. Int J Cardiovasc Imaging. 2019 Feb;35(2):215-223. doi: 10.1007/s10554-019-01529-5. Epub 2019 Feb 22. Int J Cardiovasc Imaging. 2019. PMID: 30796556
209 results